NCT01048814View on ClinicalTrials.gov

Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases

CompletedOBSERVATIONAL
Enrollment

512

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Interventions
OTHER

ChemoFx

Chemoresponse Marker Assay

Trial Locations (1)

15203

Precision Therapeutics, Inc., Pittsburgh

Sponsors
All Listed Sponsors
lead

Precision Therapeutics

INDUSTRY